By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor Regains All Rights From Amgen (AMGN) To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes 10/29/2014 6:16:06 AM
Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development And Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 9/3/2014 11:25:37 AM
Xencor To Present At Wedbush Securities 2014 Life Sciences Management Access Conference 8/5/2014 8:03:22 AM
Xencor Reports Second Quarter 2014 Financial Results 8/1/2014 6:45:45 AM
Xencor To Host Second Quarter 2014 Financial Results Webcast And Conference Call 7/24/2014 10:44:15 AM
Xencor Appoints Kurt Gustafson To Board Of Directors; Promotes John Desjarlais To Chief Scientific Officer 7/15/2014 9:51:10 AM
Xencor Initiates Phase 1 Study Of XmAb7195 For Asthma 5/28/2014 9:04:44 AM
Xencor To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/22/2014 7:02:45 AM
Xencor Presents Study Comparing XmAb7195 To Omalizumab At The American Thoracic Society 2014 International Conference 5/15/2014 7:42:16 AM
Xencor Reports First Quarter 2014 Financial Results 5/15/2014 6:21:35 AM